↓ Skip to main content

Anaplastic Thyroid Carcinoma: Expression Profile of Targets for Therapy Offers New Insights for Disease Treatment

Overview of attention for article published in Annals of Surgical Oncology, November 2006
Altmetric Badge

Mentioned by

f1000
1 research highlight platform

Citations

dimensions_citation
102 Dimensions

Readers on

mendeley
45 Mendeley
Title
Anaplastic Thyroid Carcinoma: Expression Profile of Targets for Therapy Offers New Insights for Disease Treatment
Published in
Annals of Surgical Oncology, November 2006
DOI 10.1245/s10434-006-9178-6
Pubmed ID
Authors

Sam M. Wiseman, Hamid Masoudi, Paddy Niblock, Dmitry Turbin, Ashish Rajput, John Hay, Samuel Bugis, Douglas Filipenko, David Huntsman, Blake Gilks

Abstract

Anaplastic thyroid cancer is an endocrine malignancy. Its rare and rapidly lethal disease course has made it challenging to study. Little is known regarding the expression by anaplastic tumors of molecular targets for new human anticancer agents that have been studied in the preclinical or clinical setting. The objective of this work was to evaluate the expression profile of anaplastic thyroid tumors for molecular targets for treatment.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ukraine 1 2%
Germany 1 2%
Unknown 43 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 31%
Student > Ph. D. Student 5 11%
Other 3 7%
Student > Master 3 7%
Student > Doctoral Student 2 4%
Other 9 20%
Unknown 9 20%
Readers by discipline Count As %
Medicine and Dentistry 17 38%
Agricultural and Biological Sciences 9 20%
Biochemistry, Genetics and Molecular Biology 5 11%
Psychology 2 4%
Business, Management and Accounting 1 2%
Other 0 0%
Unknown 11 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 March 2007.
All research outputs
#15,233,109
of 22,649,029 outputs
Outputs from Annals of Surgical Oncology
#4,348
of 6,416 outputs
Outputs of similar age
#60,534
of 69,090 outputs
Outputs of similar age from Annals of Surgical Oncology
#33
of 34 outputs
Altmetric has tracked 22,649,029 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,416 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 69,090 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.